Company intelligence / Profile preview
Belmedpreparaty
Minsk, Belarus
- Ownership
- Private
- Development stage
- Other
01
Overview
Belmedpreparaty is Belarus’s leading pharmaceutical manufacturer, producing approximately 360 products, including insulin (the only producer in Belarus), anticancer agents, antibiotics, narcotics/psychotropic substances, and drugs for tuberculosis and other major diseases. Its portfolio covers almost all dosage forms and key products are approved and supplied domestically and to at least 14 export markets[1][2][4].
- Therapeutic areas
- OncologyInfectious DiseasesEndocrinologyPsychiatry
- Modalities
- Small moleculeBiologicProtein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Belarus health ministryITM Investment-Trade-Marketing GmbH
Beyond the preview
Go deeper on Belmedpreparaty.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Belmedpreparaty.